Immunity after COVID-19: Protection or sensitization?

Area of Science:

• Immunology
• Epidemiology
• Infectious Diseases

Background:

• Clinical observations suggest COVID-19 infection might not confer lasting immunity.
• Antibody-dependent enhancement (ADE) is a documented phenomenon in other viral infections.
• Previous SARS epidemic (2003) provides a comparative context for understanding viral evolution.

Purpose of the Study:

• To investigate the impact of initial COVID-19 infection failing to provide immunity.
• To explore how sensitization to future SARS-CoV-2 challenges affects epidemic trajectories.
• To quantify potential increases in severe cases and deaths due to immune fragilization.

Main Methods:

• Utilized a compartmental epidemic model stratified by immunity levels.
• Fitted the model to available epidemiological data.
• Simulated various scenarios of immune fragilization dynamics.

Main Results:

• Model projections indicate potential for unfavorable immune evolution post-initial infection.
• Quantitative estimates derived for additional severe cases and deaths under sensitization scenarios.
• Comparison with SARS epidemic highlights potential differences in immune response.

Conclusions:

• Initial SARS-CoV-2 infection may lead to immune sensitization rather than protective immunity.
• Immune fragilization could significantly worsen future epidemic waves.
• Further research is needed to understand long-term immunity and inform public health strategies.